文献速递慢阻肺呼吸道感染

AERIS研究:肺微生物组纵向分析显示细菌性和嗜酸性COPD急性加重具有可重复性

Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations.
PubMed 文献 · Thorax · 2018-01-31

AERIS研究对101例COPD患者1年内584份痰标本进行16S rRNA基因高通量测序,分析稳定期与急性加重期肺微生物组变化。结果显示急性加重期及高加重频率者微生物组稳定性更易下降;马尔可夫链模型分析表明细菌性和嗜酸性急性加重在同一患者后续加重中更易重复,而病毒性加重则不然。研究还证实嗜血杆菌和莫拉菌等细菌属与疾病严重程度、急性加重事件及支气管扩张相关。

要点

  • COPD急性加重期及高加重频率患者肺微生物组稳定性更易下降。
  • 细菌性和嗜酸性急性加重在同一患者后续加重中更易重复,病毒性则不。
  • 嗜血杆菌和莫拉菌等细菌属与疾病严重程度、急性加重及支气管扩张相关。

核心结论

  • COPD不同亚型具有不同的细菌组成和时间稳定性,部分急性加重亚型在未来加重中具有非随机的重复概率。

研究设计与样本

  • AERIS研究(急性加重与呼吸道感染在COPD中)对101例COPD患者1年内584份痰标本进行16S rRNA基因高通量测序,结合微生物学、血液标志物和深入临床评估分类COPD表型。

主要发现

  • 急性加重期及高加重频率个体中肺微生物组随时间稳定性更易下降。
  • 马尔可夫链模型分析显示细菌性和嗜酸性急性加重在同一患者后续加重中更易重复,而病毒性急性加重则不然。
  • 嗜血杆菌和莫拉菌等细菌属与疾病严重程度、急性加重事件及支气管扩张相关。

临床怎么用

  • 有助于识别肺内细菌靶标和生物标志物以分类COPD亚型并确定合适治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Alterations in the composition of the lung microbiome associated with adverse clinical outcomes, known as dysbiosis, have been implicated with disease severity and exacerbations in COPD. OBJECTIVE: To characterise longitudinal changes in the lung microbiome in the AERIS study (Acute Exacerbation and Respiratory InfectionS in COPD) and their relationship with associated COPD outcomes. METHODS: We surveyed 584 sputum samples from 101 patients with COPD to analyse the lung microbiome at both stable and exacerbation time points over 1 year using high-throughput sequencing of the 16S ribosomal RNA gene. We incorporated additional lung microbiology, blood markers and in-depth clinical assessments to classify COPD phenotypes. RESULTS: The stability of the lung microbiome over time was more likely to be decreased in exacerbations and within individuals with higher exacerbation frequencies. Analysis of exacerbation phenotypes using a Markov chain model revealed that bacterial and eosinophilic exacerbations were more likely to be repeated in subsequent exacerbations within a subject, whereas viral exacerbations were not more likely to be repeated. We also confirmed the association of bacterial genera, including Haemophilus and Moraxella, with disease severity, exacerbation events and bronchiectasis. CONCLUSIONS: Subtypes of COPD have distinct bacterial compositions and stabilities over time. Some exacerbation subtypes have non-random probabilities of repeating those subtypes in the future. This study provides insights pertaining to the identification of bacterial targets in the lung and biomarkers to classify COPD subtypes and to determine appropriate treatments for the patient. TRIAL REGISTRATION NUMBER: Results, NCT01360398.

来源:Thorax,查看原文。版权归原作者所有。

引用

  1. Mayhew D, Devos N, Lambert C, et al. Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations. Thorax. 2018. PMID: 29386298. doi:10.1136/thoraxjnl-2017-210408

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。